AWM Investment Company, Inc. 13D and 13G filings for OncoCyte Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 2:41 pm Purchase |
2024-12-31 | 13G | OncoCyte Corporation OCX |
AWM Investment Company, Inc. | 1,306,309 7.500% |
1,306,309 (New Position) |
Filing |